Alan Rosmarin to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Alan Rosmarin has written about Dose-Response Relationship, Drug.
Connection Strength
0.025
-
Reagan JL, Rosmarin A, Butera JN, Nadeem A, Schiffman FJ, Sikov WM, Winer E, Mega AE. Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL. Cancer Chemother Pharmacol. 2011 Oct; 68(4):1075-80.
Score: 0.020
-
Mazur EM, Rosmarin AG, Sohl PA, Newton JL, Narendran A. Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans. Blood. 1992 Apr 15; 79(8):1931-7.
Score: 0.005